Cellular Transplants Inc. has received $2.5 million in insuredbond financing from the state of Rhode Island to renovate abuilding in Lincoln as a pilot manufacturing plant and to buyequipment.
The plant, expected to come on line in 1992, will produce thecompanyLs cell implants to deliver a potential treatment forParkinsonLs disease that is now in preclinical development.
Based in Providence, the company is developing living cells,encapsulated by a membrane that protects them from immunerejection, to deliver a variety of proteins and neurotransmittersthat are deficient in certain diseases.
(c) 1997 American Health Consultants. All rights reserved.